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Abstract
The intersection of global broadband technology and miniaturized high-capability 
computing devices has led to a revolution in the delivery of healthcare and the birth of 
telemedicine and mobile health (mHealth). Rapid advances in handheld imaging devices 
with other mHealth devices such as smartphone apps and wearable devices are making 
great strides in the field of cardiovascular imaging like never before. Although these 
technologies offer a bright promise in cardiovascular imaging, it is far from straightforward. 
The massive data influx from telemedicine and mHealth including cardiovascular imaging 
supersedes the existing capabilities of current healthcare system and statistical software. 
Artificial intelligence with machine learning is the one and only way to navigate through this 
complex maze of the data influx through various approaches. Deep learning techniques are 
further expanding their role by image recognition and automated measurements. Artificial 
intelligence provides limitless opportunity to rigorously analyze data. As we move forward, 
the futures of mHealth, telemedicine and artificial intelligence are increasingly becoming 
intertwined to give rise to precision medicine.
Introduction
Technological advancement has developed portable 
computer devices and miniaturized cardiac imaging 
devices. These devices with the simultaneous development 
of broadband technologies has led to a new frontier 
in communication by expanding the capabilities of 
information sharing among users worldwide. The effects 
of this digital landscape have permeated through multiple 
facets of daily life. Telemedicine and mobile health 
(mHealth), which is defined as use of mobile and wireless 
technologies to improve health care (1, 2), are becoming 
important in this digital landscape with cardiovascular 
medicine and the field of echocardiography being no 
exception. The Department of Health and Human 
Services estimates that more than 60% of all health care 
institutions in the United States currently use some form 
of telemedicine (3). Handheld imaging platforms and 
tele-interpreting has brought these trends into the field of 
echocardiography (4, 5).
Although big data generated by the telemedicine 
and cardiac imaging present great opportunity for 
cardiovascular research, this influx of data requires 
so much effort to integrate and interpret them that 
human cardiologists cannot digest all of it (6). Artificial 
intelligence (AI), including machine learning techniques, 
is increasingly recognized as a potential solution for 
facilitating a seamless transition between cardiologists 
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and big data. AI can integrate the multifactorial 
information from many aspects of healthcare, including 
echocardiographic data, and can help cardiologists 
make better clinical decisions even in resource-limited 
areas where experts are not readily accessible. mHealth, 
telemedicine and AI offer bright promises intertwined 
with complex challenges in the field of cardiology 
and imaging. In this review, we will discuss the role of 
mHealth, telemedicine and AI in echocardiography.
Mobile health
Handheld imaging devices
As mobile computers and handheld imaging platforms 
become easily accessible and readily available, they 
present new paths of opportunity for the delivery and 
optimization of cardiovascular healthcare. Since the 
dawn of medicine, physical examination has been 
central to point-of-care diagnosis in cardiovascular 
medicine. The rapid rise of imaging devices which help 
physicians visualize the heart’s activities in real time have 
complemented physical examination and augmented 
clinical decision making. Despite the wide array of imaging 
capabilities at our disposal, correct diagnosis are not 
always made in time resulting in unfavorable outcomes 
(7). This has perpetuated a need, no a necessity for rapid 
and efficient diagnosis at bedside. The development of 
miniaturized handheld imaging platforms such as the 
pocket-size ultrasound can circumvent the obstacles of 
delayed diagnosis and reduce medical errors (7). There 
are several types of handheld ultrasounds with various 
capabilities; a laptop-based equipment has almost every 
2D echocardiographic application, while a pocket-size 
ultrasound does not usually have full-scale color-flow 
and spectral Doppler capabilities (Fig.  1). The point-
of-care ultrasound (POCUS) can fundamentally alter 
bedside medicine and be indispensable with physical 
examination. There are numerous studies which have 
clearly shown that POCUS is as efficient and effective 
compared to conventional machines. (8, 9, 10, 11, 12, 
13, 14, 15, 16, 17, 18) Many researches have shown their 
capability in the assessment of valvular heart disease (19, 
20), heart failure (21, 22, 23), coronary artery disease (22, 
24) and so forth. (Table 1). Accuracy of POCUS has been 
reported well. For example, Abe et al. studied 130 patients 
with aortic stenosis and reported that pocket ultrasound 
was able to discriminate moderate-to-severe aortic stenosis 
with sensitivity 84% and specificity 90% even without 
quantitative Doppler information (19). Most recently, 
there are some smartphone-sized devices with image 
quality well enough for cardiac assessment using AI-based 
technologies. Some of these devices are supposedly 
financially cheap and help cardiologists in practice (e.g. 
Vscan, GE Healthcare and Butterfly IQ, Israel).
With powerful and affordable diagnostic imaging 
devices at the palm of our hands, POCUS can augment and 
add a significant impact on cardiovascular healthcare (25, 
26, 27, 28, 29), especially in patients living in resource-
limited areas.
Figure 1
Type of handheld ultrasound machines. There are 
several types of handheld ultrasounds with 
various capabilities; a laptop-based equipment 
has almost every 2D echocardiographic 
application (panel A), while a pocket-size 
ultrasound does not usually have full-scale 
color-flow and spectral Doppler capabilities (panel 
B). Reproduced, with permission, from Chamsi-
Pasha et al. (4).
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to PUS Study findings
Prinz et al. (8) 2011 349 Standard 
echocardiography
Statistically significant agreement between PUS and high-end 
echocardiography (1.6 ± 0.5 vs 1.7 ± 0.4, P < 0.01), regional wall 
motion (κ = 0.73, P < 0.01), LV measurements (r = 0.99, P < 0.01), 
regurgitation detection (k = 0.9, P < 0.01)
Galderisi et al. (9) 2010 304 Standard 
echocardiography
The K between PUS and reference was 0.67 in the pooled 
population (0.84 by experts and 0.58 by trainees)
Testuz et al. (10) 2013 104 Standard 
echocardiography
Statistically significant agreement between PUS and reference for 
left ventricular function and pericardial effusion (kappa: 0.89 and 
0.81). The agreement for aortic, mitral, tricuspid and left 
ventricular size was moderate (Kappa: 0.55–0.66)
Andersen et al. (11) 2011 108 Standard 
echocardiography
Strong agreement between PUS and reference for abdominal aorta 
and pericardial effusion was (r ≥ 0.92), right ventricular and 
valvular function (r ≥ 0.81). The correlation for aortic stenosis was 
(r = 0.62)
Skjetne et al. (7) 2011 119 Standard 
echocardiography
The PUS accurately assessed and diagnosed only 16% of patients in 
the cardiac unit. In 55% of patients, the reference had higher 
diagnostic value
Lafitte et al. (12) 2011 100 Standard 
echocardiography
The concordance between PUS and reference for LV function and 
morphology (κ = 0.91 and 0.96), left ventricular hypertrophy 
(k = 0.74), mitral regurgitation grades were 0.90, 0.95, and 1.00
Michalski et al. (13) 2012 220 Standard 
echocardiography
There was excellent correlation between PUS and reference (r =  
0.64–0.96, P < 0.001)
Biais et al. (14) 2012 151 Standard 
echocardiography
The PUS had good accordance with the reference in global left 
ventricular systolic dysfunction (κ = 0.87), pericardial effusion 
(κ = 0.75)
Prinz et al. (15) 2012 320 Standard 
echocardiography
In comparison to reference, substantial agreement in functional 
assessment (κ > 0.61, P < 0.01) and wall motion scoring (κ = 0.67, 
P < 0.01) could be observed over time. The correlation in left 
ventricular measurements (r > 0.98, P < 0.01) was very good
Fukuda et al. (16) 2009 125 Standard 
echocardiography
Left ventricular dimensions, fractional shortening, interventricular 
septum thickness, posterior wall thickness, left atrial dimension, 
and aortic diameter show excellent correlation (r = 0.87–0.98, all 
P < 0.001)
Mjolstad et al. (17) 2012 196 Standard 
echocardiography
Excellent agreement was observed between PUS and reference
Panoulas et al. (18) 2013 122 Standard 
echocardiography
After addition of PUS, there was improved diagnostic accuracy 
(Z = −7.761, P < 0.001)
Carlino et al. (25) 2018 102 Standard 
echocardiography
After addition of PUS, it helped improve diagnostic accuracy (all 
P < 0.01 vs single modalities)
Bhavnani et al. (39) 2018 254 Standard 
echocardiography
PUS had a shorter time to referral for intervention (83 ± 79 days vs 
180 ± 101 days; P < 0.001). The PUS group had lower risk of 




2017 100 Standard 
echocardiography
There was statistically significant correlation between PUS and 
reference for intimal medial thickness (r = 0.58; 95% CI: 0.48–0.66; 
P < 0.0001)
Phillips et al. (22) 2017 102 Standard 
echocardiography
In relation to reference, PUS had values ranging from 85% for left 
atrial enlargement to 100% for cardiomegaly, but limited specificity 
of cardiomegaly at just 51%
Esposito et al. (27) 2017 508 Standard 
echocardiography
In a subgroup, PUS was compared with the standard for abdominal 
aorta size (rho = 0.966, P < 0.0001)
Cavallari et al. (28) 2015 100 Standard 
echocardiography
The PUS had a shorter time for examination (6.1 ± 1.2 min vs 
13.1 ± 2.6 min, P < 0.0001) and saved waiting time (P < 0.001). No 
difference in conclusiveness between both groups (86 vs 96%; 
P = 0.08)
Khan et al. (29) 2014 240 Standard 
echocardiography
No discernable differences between both groups (P = 7.22 × 10(-7)). 
PUS, pocket-size ultrasound.
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There are more than 160,000 health-related smartphone 
apps, such as apps for monitoring weight or diet control, 
available and these apps have been downloaded close to 
660 million times (30, 31, 32). In addition, there have 
been many smartphone-connected devices and wearable 
devices available, which enable remote monitoring of 
health conditions including heart rhythm and blood 
pressure (30, 33, 34, 35). One of the hottest topics in the 
field is detection of atrial fibrillation using smartwatch. 
Tison et al. compared smartwatch data with standard ECG 
in 9750 patients for detecting atrial fibrillation (36). A deep 
learning-based algorithm showed excellent prediction of 
atrial fibrillation (C-statistic 0.97) with a sensitivity of 98% 
and specificity of 90.2%. Those apps and devices, along 
with other devices such as point-of-care measurements 
of B-type natriuretic peptide (BNP) (37) and implantable 
pulmonary artery pressure sensors (38), have potential to 
provide better identification of underlying diseases and 
improve their outcomes in communities (Fig. 2).
Integration of handheld imaging platforms with 
other mHealth devices
Bhavnani et  al. conducted the first randomized trial of 
integration of POCUS with other mHealth devices in 
modern structural heart disease clinics in rural parts of 
India, under the ASE Foundation-Valvular Assessment 
Leading to Unexplored Echocardiographic Stratagems 
(ASEF-VALUES) (39). There were a total of 253 patients 
with structural heart disease randomized into two 
groups of mHealth clinic and standard healthcare. The 
main focus was the impact of mHealth with pocket-size 
echocardiography on medical decision making in patients 
with valvular heart disease in remote areas. The primary 
objective was time to referral for management for surgical 
or percutaneous intervention. The initial mHealth clinic 
was associated with shorter referral time for intervention 
(83 ± 79  days vs 180 ± 101  days; P < 0.001) and increased 
probability for intervention compared with standard 
healthcare (adjusted hazard ratio, 1.54; 95% CI, 0.96–2.47, 
P < 0.07). The patients assigned to mHealth clinic had 
lower hospitalization and death (15% vs 28%, adjusted 
hazard ratio, 0.41; 95% CI, 0.21–0.83; P < 0.013). In this 
study, the authors successfully integrated POCUS with 
other mHealth devices and showed that this integration 
can be associated with earlier medical interventions and 
favorable clinical outcome.
Telemedicine with POCUS and 
mHealth devices
Feasibility of POCUS in telemedicine
Thus, pocket-size ultrasound and other mHealth devices 
have allowed point-of-care screening of cardiovascular 
Figure 2
Interrogation of mHealth devices and use of artificial intelligence. Technological advancement has created a number of mobile health devices, which are 
available even in resource-limited areas. Involving remote experts using telemedicine helps appropriate diagnosis and management. Artificial intelligence 
can efficiently address the lack of experts and the influx of complex data generated by mHealth and telemedicine as well as advanced imaging 
modalities.
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diseases to resource-limited communities. Furthermore, 
application of telemedicine technologies enables 
mHealth strategies even in remote areas with limited 
access to experts. Singh et  al. (40) under American 
Society Echocardiography: Remote Echocardiography 
with Web-Based Assessments for Referral at a Distance 
(ASE-REWARD) performed a prospective study in order 
to test the feasibility of performing POCUS with long-
distance Web-based assessment of recorded images. 
Using pocket-size ultrasound, 1023 studies were scanned 
in a rural region of India, and the images were sent to 
physicians in remote locations for review through Web-
based platforms. The images were successfully uploaded 
and reviewed at a median time of 11:44 h. There was an 
excellent agreement in assessing valvular lesions, whereas 
the on-site readings were frequently modified by expert 
reviewers for left ventricular function and hypertrophy. 
The study successfully showed the feasibility of remote 
echocardiographic assessment and the incremental value 
of using Web-based remote assessment for facilitating 
appropriate mass triage of patients with suspected cardiac 
illnesses.
Choi et  al. (41) tested the feasibility of remote 
interpretation of echocardiographic images on a 
smartphone. Eighty-nine patients underwent POCUS and 
the images were sent to remote experts who read them 
using smartphone apps. The authors found that 38% 
of on-site, non-expert diagnosis was revised by remote 
experts, whose interobserver agreement was excellent. 
The study suggested that remote interpretation is feasible 
and should be considered when POCUS is done by non-
experts.
Limitations of POCUS
Although the benefits of POCUS are promising, there have 
been several challenges for its clinical application. One of 
the biggest concerns is the standardization of the quality 
of scan and interpretation (4). Because of its availability, 
POCUS can be used in more various situations and by 
wider range of observers than standard echocardiography. 
On the other hand, POCUS has limited ability in terms of 
image quality and applications such as pulse-wave Doppler. 
Scanning patients using POCUS and interpreting images 
by novice observers can result in overlooking important 
findings and wrong diagnosis (4). It is absolutely pivotal 
for all healthcare providers who use POCUS to be properly 
trained and understand the limitations of POUCS. Most 
professional societies require a minimum of 30 scans for 
basic training, but this number is not enough for accurate 
interpretation. Universal standardization of training is 
necessary for wide use of POCUS in clinical practice. Some 
of these limitations can be addressed by AI. For example, 
AI-based automated LVEF analysis program that works on 
PUS images (LVivo by DiA Imaging Analysis Ltd., Israel and 
Vscan by GE Healthcare) has been developed (42). This 
kind of programs will reduce the interobserver variability 
and help standardization of procedures. The lack of 
incentive for POCUS in US healthcare model is another 
problem, because more referrals and reimbursement 
for conventional echocardiography is more beneficial. 
A reward system is important to stimulate increased 
utilization.
Remote training and robot-assisted  
echocardiography
Even telemedicine enables remote assessment of acquired 
echocardiographic images, and appropriate acquisition 
itself requires expertise, which may limit its wider use in 
rural areas. Telemedicine also has a potential to address 
this issue through Web-based training. Bansal et al. (43) 
tested the feasibility of Web-based, real-time, hands-on, 
personalized training program of POCUS. Seventeen 
physicians in India were provided 6-h training of POCUS; 
nine had an on-site training and eight had an online 
training using transcontinental tele-echocardiography 
system. Although good-quality images were obtained 
more frequently by physicians trained on-site (90 vs 84%, 
P = 0.03), there were no difference between the two groups 
in agreement of the trained physicians’ diagnoses with 
expert interpretations. Such training, combined with 
Web-based integration of remote, expert interpretation of 
stored images, allows the delivery of echocardiographic 
expertise to remote communities, which could be of great 
help in optimizing cardiovascular health outcomes.
Robot-assisted remote echocardiography may be 
another solution. Boman et  al. conducted randomized 
control trial and showed that real-time robot-assisted 
remote echocardiography followed by cardiologic 
consultation at a distance significantly reduced the total 
diagnostic process time (44).
Advanced echocardiography in contrast 
to POCUS
As discussed earlier, POCUS is promising and has a 
huge impact in expanding and complimenting physical 
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examination. However, those handheld imaging 
platforms have limited function, and comprehensive 
and advanced echocardiography is definitely 
warranted in addition to POCUS. Recent advancement 
in echocardiography includes automation of 
measurements and analysis. Although speckle tracking 
echocardiography (STE) and 3D imaging have been the 
most promising methods in echocardiography for the 
past two decades, clinical use of these techniques is not 
sufficient due to time-consuming process. Automation 
of these techniques using AI algorithms are evolving 
and they help physicians and sonographers by reducing 
analysis time and increasing reproducibility (45, 46, 47). 
This is also a field where AI has a core role for evolution 
and for widespread use of the techniques. For example, 
although 3D echocardiography has been extensively 
reported to be superior to 2D echocardiography, the 
full adoption of this technique is not embraced due 
to time constraints and complicated measurement 
steps which disrupt clinical work flow. HeartModel 
(Philips Healthcare, Andover, MA, USA) is an AI-based 
fully automated quantification program for left heart 
chambers. The program dramatically reduces time for 
analysis (144 ± 32 to 26 ± 2 min, P < 0.0001) with even 
better interobserver measurement agreement compared 
with conventional 3D quantification (48, 49).
Artificial intelligence
Despite the transformative potential of mHealth and 
telemedicine, the data generated by these technologies 
are multifactorial and complex. In addition, imaging 
modalities including echocardiography also generate a 
huge amount of data; a single echo examination generates 
2 gigabyte of information and annually there can be 15 
petabytes of information produced (50). This large size of 
data would overwhelm current statistical software. AI is a 
field of computer science which mimics human thought 
process and learning capacity. AI could algorithmically 
quickly analyze and offer various interpretations of these 
elaborate datasets with lesser difficulty. With the rapid 
evolution of data, AI will be the primary and most efficient 
tool which brings the necessary revolution for integration 
of information into cardiovascular healthcare. In resource-
limited situations where mHealth and telemedicine have 
an important role, well-trained AI may complement 
the lack of experts. AI techniques, such as machine 
learning and deep learning, unravel hidden patterns 
within heterogeneous datasets using a number of various 
algorithms (50). With the advent of AI, the paradigm is 
being fundamentally altered from current statistical tools 
to cardiovascular precision medicine (Fig. 3) (51).
Type of machine learning
Machine learning is one subfield of AI, which aims at 
automatic discovery of regularities in data through the 
use of computer algorithms and generalizing those into 
new but similar data (Fig. 4). In general, machine learning 
tends to make less pre-assumption than traditional 
statistical method but requires greater data. Machine 
leaning techniques can be broadly split into supervised 
learning, unsupervised learning and reinforcement 
learning.
In supervised learning, the database is labeled with 
outcome and classes. Supervised learning frequently 
groups an observation into one or more categories or 
outcomes (51). It is ultimately designed to show how 
the independent variable is linked to the dependent 
variable. A statistical model is generated from the data 
to create a model to predict an event or complication. 
Supervised learning proves to be very valuable in 
classifying phenotypically different patients (51). In 
contrast to supervised learning, unsupervised learning 
uses database with no prior label present (34). The 
purpose of unsupervised learning is to discover the 
Figure 3
Growth of publications in machine learning. The x- and y-axis shows the 
year and the number of publications in PubMed with ‘Cardiology’ and 
‘Machine Learning’. The number of publications is rapidly growing, 
representing huge interest in the field. Reproduced, with permission, 
from Shameer et al. (50).
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relationship between variables. This machine-learning 
approach consists of clustering methods (hierarchical 
or K means), self-organizing maps, topological data 
analysis, information maximization analysis and finally 
deep learning. Reinforcement learning is derived from 
behavioral psychology. The algorithm learn and modify 
behavior through trial and error so as to maximize some 
notion of cumulative reward (51). Reinforcement learning 
is mostly used in game programs, such as AlphaGo 
software by DeepMind (52). Reinforcement learning has 
had limited role in healthcare so far.
Deep learning
Deep learning is a thriving discipline which learns complex 
hierarchical representations from data which has multiple 
levels of abstractions (53). It mimics the complexities of 
the human brain. Presently, deep learning is playing a 
prominent role in Facebook’s image recognition, speech 
recognition in Apple’s Siri and Amazon’s Alexa, Google 
brain and robots (53). Deep learning architecture utilizes 
an artificial neural network which contains multiple layers 
of neurons which facilitates reasoning and interpretation. 
Recent advances in graphic processing unit and cloud-
based platforms have spurred the growth of deep learning.
Deep learning requires a large elaborate data sets 
which requires information sharing between institutions 
and organizations. If the dataset is not large enough, 
overfitting is an issue (50). It has multiple layers and 
performs analysis in a nonlinear manner. This also 
increases the training time. Assembling the neural network 
is also lengthy process. Powerful computing processing 
unit and cloud-based systems are often necessary for deep 
learning.
Comparison of machine learning with 
traditional statistics
Logistic regression is one of the most commonly used 
methods in statistics to predict outcomes (50). However, 
this technique requires a strong number of assumptions 
to help generate P values. Nevertheless, machine 
learning can be used in any data set without making 
any assumptions of the underlying data. Especially for 
classification, machine learning can be more accurate and 
predictive. Another difference is the capability to deal with 
complex data. Electronic health record contains a massive 
amount of information from billing, international disease 
classification, lab values, imaging and medications. 
This can exceed the capacity of logistic regression 
model. Other statistical approaches such as univariate 
significance screening or stepwise regression, but the 
results do not translate well for patient care. Complex 
interaction between variable may be difficult to analyze 
with traditional approaches. Churpek et al. showed how 
flexible algorithms in machine learning was superior to 
conventional logistic regression for clinical deterioration 
in wards in a large multihospital study (54). Popular 
risk scores such as Framingham risk score, CHADS2 and 
CHA2DS2-VASc score, and so forth were derived from 
large trials and registries (55). However, Cook et al. found 
that there was an overestimation of these pooled cohort 
equations, believed that big data analytics could resolve 
the issue (56).
The role of machine learning in cardiology 
and echocardiography
Many machine-learning and deep learning techniques 
can be applied to researches in echocardiography 
Figure 4
Association of artificial intelligence, machine 
learning and deep learning. Artificial intelligence 
(AI), though there are various definitions by itself, 
represents any techniques which enables 
computers mimic human behavior when it’s used 
in medical field. Machine learning is a subfield of 
AI, which aims at automatic discovery of 
regularities in data through the use of computer 
algorithms and generalizing those into new but 
similar data. Deep learning is a subset of machine 
learning, which makes the computation of 
multi-layer neural networks feasible.
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(Table 2) (38, 48, 57, 58, 59, 60). For example, we showed 
that supervised learning algorithm, including artificial 
neural networks, support vector machines and random 
forests, could differentiate athlete heart and hypertrophic 
cardiomyopathy using STE data more accurately than 
traditional measures (58). We have also used supervised 
learning approach with 15 STE variables and the four 
conventional echocardiographic variables and showed 
that machine learning was superior to other echo 
parameters for differentiating constrictive pericarditis 
from restrictive cardiomyopathy (57).
Deep learning is being utilized for a number of 
image-based classifications. This machine learning 
approach is particularly useful for computer vision. Deep 
learning can track pattern recognition in cardiovascular 
imaging and heterogeneous syndromes. Left ventricular 
ejection fraction is usually assessed by manually tracing 
boundaries (53), but unfortunately this method can be 
subjective lack precision or reproducibility (61). Deep 
learning can greatly improve the accuracy of 2D STE and 
other imaging modalities (48, 59). This can be extended 
into other cardiovascular imaging modalities such as 3D 
STE and cardiac magnetic resonance imaging. It performs 
well even with noisy data such as strain imaging. 
Deep learning can be implemented into a number of 
cardiovascular diseases including heart failure, takotsubo 
cardiomyopathy, hypertension, atrial fibrillation, Brugada 
syndrome and so forth. It can categorize these conditions 
with new genotypes or phenotypes and innovative 
echocardiographic parameters can craft pathways for new 
therapies.
Recently, Zhang et  al. developed a deep learning 
algorithm that enables fully automated interpretation of 
echocardiography (62). Using a huge (over 14,000) sample 
of echocardiographic studies, the algorithm achieved 
a 96% accuracy in image recognition for distinguishing 
Table 2 Examples of application of machine learning techniques to echocardiographic research.
Study Algorithm model Brief algorithm description Data source Brief study description
Narula et al. (58) (a) Support vector 
machine
Finds a gap in 
multidimensional data 
and classifies data based 
on gap
Echocardiographic data To differentiate between 
athlete heart and 
hypertrophic 
cardiomyopathy
(b) Random forest Decision tree-based 
method derived from 
creating a number of 
decision trees
(c) Artificial neural 
network
Learns in a manner similar 
to a biological network
Sengupta et al. (57) Associative memory 
classifier-supervised 
learning
Used for making 
predictions based on a 
set of matrices. It is 







To differentiate between 
constrictive pericarditis and 
restrictive cardiomyopathy
Berikol et al. (48) Artificial neural network Echocardiographic data Echocardiographic data and 
clinical factors used to 
stratify cardiovascular risk
Lancaster et al. (59) Hierarchical 
clustering
It classifies similar objects 
into the same groups 
called clusters by building 
a hierarchy based on the 
distance between 
patients
Echocardiographic data To investigate the natural 
clustering of 
echocardiographic variables 
to measure left ventricular 
dysfunction and isolate 
high-risk phenotyping 
patterns
Abdolmanafi et al. (38) Deep learning It creates layered neural 
networks to extract and 
transform features and 






To automatically classify 
coronary artery layers in 
coronary optical coherence 
tomography images in 
Kawasaki disease
Bai et al. (60) Cardiac magnetic 
resonance
Deep learning was used to 
analyze short and long axis 
cardiac magnetic resonance 
imaging and compare with 
human performance
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between broad echocardiographic view classes (e.g. 
parasternal long axis from short axis), and 72–90% 
accuracy of image segmentation. Furthermore, the authors 
showed that the algorithm for automated quantification 
of cardiac structure and function was comparable or even 
superior to manual measurements across 11 internal 
consistency metrics (e.g. the correlation of left atrial and 
ventricular volume) and that the convolutional neural 
networks was successfully trained to detect hypertrophic 
cardiomyopathy, cardiac amyloidosis and pulmonary 
artery hypertension with high accuracy. Although the 
accuracy has not reached that of experts, application 
of deep learning to echocardiography interpretation is 
promising.
Future of artificial intelligence in cardiology
The rapid expansion of data is creating a moment 
of reckoning of sorts for cardiologists. With the 
development of POCUS integrated with mHealth devices 
and telemedicine, a concept which once seemed like a 
fantasy is now becoming a reality. AI, mainly machine 
learning techniques including deep learning, is the 
most effective means presently available to handle the 
sheer complexity data incoming from these evolutions. 
Compared to subspecialties of medicine, cardiologists 
have vast expanses of data at their disposal. As the 
complexities of data continue to grow, it is becoming 
imminent for an AI to be integrated into clinical practice. 
AI will become part and parcel of daily medicine, which 
is evidenced in the fields of radiology and pathology (63). 
It should be embraced not feared as it will enhance the 
clinical decision-making process. In the future, it may be 
necessary for all cardiologists to be physicians and data 
scientists simultaneously.
Conclusion
The burgeoning of mHealth, telemedicine and AI are 
the expanding the boundaries of echocardiography and 
cardiology. mHealth and telemedicine are establishing 
new bridges between patient and physician and 
helping underserved population to overcome previous 
barriers with their health care providers. AI is the truss 
support for these bridges. AI is the primary means 
and will be interconnected with the growth of these 
novel healthcare technologies for years to come. As 
mHealth and telemedicine create big data even in 
resource-limited areas where the number of experts 
is not sufficient and big data from these technologies 
are getting more and more complex, AI will assist 
cardiologists to provide more focused and personalized 
decision for the patients.
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